154 related articles for article (PubMed ID: 3531653)
1. The role of V antigen in mice experimentally infected with Yersinia pseudotuberculosis; histopathological study using enzyme immunoassay.
Sugiyama Y; Kaneko K; Takashima I; Hashimoto N
Nihon Juigaku Zasshi; 1986 Aug; 48(4):781-9. PubMed ID: 3531653
[No Abstract] [Full Text] [Related]
2. Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes.
Rosenheinrich M; Heine W; Schmühl CM; Pisano F; Dersch P
PLoS One; 2015; 10(8):e0136290. PubMed ID: 26296209
[TBL] [Abstract][Full Text] [Related]
3. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J
Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
[TBL] [Abstract][Full Text] [Related]
5. Serological response of sheep to plasmid-encoded proteins of Yersinia species following natural infection with Y. enterocolitica and Y. pseudotuberculosis.
Robins-Browne RM; Bordun AM; Slee KJ
J Med Microbiol; 1993 Oct; 39(4):268-72. PubMed ID: 8411087
[TBL] [Abstract][Full Text] [Related]
6. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
7. Preparation of monoclonal antibody to V antigen from Yersinia pestis.
Sato K; Nakajima R; Hara F; Une T; Osada Y
Contrib Microbiol Immunol; 1991; 12():225-9. PubMed ID: 1935094
[No Abstract] [Full Text] [Related]
8. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
[TBL] [Abstract][Full Text] [Related]
9. [Findings of yersiniosis in the Crimea].
Shikulov VA; Khaĭtovich AB; Bogatyreva DM; Bandura SA; Nekrasova LI
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):36-8. PubMed ID: 2683523
[No Abstract] [Full Text] [Related]
10. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
Rastawicki W
Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalization of Th1/Th2 cytokine responses to experimental Yersinia pseudotuberculosis infection in cats.
Sukura A; Higgins J; Pedersen NC
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):139-50. PubMed ID: 9839869
[TBL] [Abstract][Full Text] [Related]
12. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
[TBL] [Abstract][Full Text] [Related]
13. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
Hudson KJ; Bouton AH
Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
[TBL] [Abstract][Full Text] [Related]
14. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.
Simonet M; Berche P; Mazigh D; Veron M
J Med Microbiol; 1985 Oct; 20(2):225-31. PubMed ID: 3900406
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the plasmid composition of Yersinia pseudotuberculosis strains and its use for typing pseudotuberculosis pathogens].
Shubin FN; Gintsburg AL; Kitaev VM; Ianishevskiĭ NV; Zenkova ZG
Mol Gen Mikrobiol Virusol; 1989 Jun; (6):20-5. PubMed ID: 2682219
[TBL] [Abstract][Full Text] [Related]
16. Precursor Abundance Influences Divergent Antigen-Specific CD8
Zhang Y; Qiu Z; Sheridan BS; Bliska JB
Infect Immun; 2021 Jul; 89(8):e0026521. PubMed ID: 34031132
[TBL] [Abstract][Full Text] [Related]
17. [Biologically active Yersinia pseudotuberculosis biopolymers].
Dzadzieva MF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):33-7. PubMed ID: 9432843
[No Abstract] [Full Text] [Related]
18. Characterization of infections with wild and mutant Yersinia pseudotuberculosis strains in rabbit oral model.
Najdenski H; Vesselinova A; Golkocheva E; Garbom S; Wolf-Watz H
Adv Exp Med Biol; 2003; 529():117-20. PubMed ID: 12756740
[No Abstract] [Full Text] [Related]
19. Morphogenesis of Experimental Infection Caused by Plasmid Variants of Yersinia pseudotuberculosis.
Somova LM; Drobot EI; Plekhova NG; Lyapun IN; Shubin FN
Bull Exp Biol Med; 2016 Dec; 162(2):264-268. PubMed ID: 27905039
[TBL] [Abstract][Full Text] [Related]
20. In vivo immunosuppression induced by a virulent strain of Yersinia pseudotuberculosis.
Simonet M; Berche P
Ann Inst Pasteur Microbiol; 1986; 137B(2):207-10. PubMed ID: 3318867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
